Maryland healthcare professionals are concerned by the short supply of IV fluid caused by the fallout from Hurricane Helene ...

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

A federal judge ordered the tech giant to let rival app stores onto its Android smartphone platform, adding to its growing ...

Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...

Pfizer is looking to use AI in a Singapore initiative to shorten the drug discovery process. Read more at straitstimes.com.

“It might start becoming the top circulating lineage,” Rajnaranayam said, predicting XEC will take the rest of October and ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held ...